Sign In
Buy ENVB
$1.98
-0.240 (-10.81%)
At Close: Jun 03, 2026
Enveric Biosciences Reports Full Year 2020 Financial Results and Provides Shareholder Update on its Accomplishments in 2021
08:01am, Thursday, 01'st Apr 2021
NAPLES, Fla., April 1, 2021 /PRNewswire/ -- Enveric Biosciences, Inc. (NASDAQ: ENVB) ("Enveric" or the "Company"), a patient-first biotechnology company developing novel cannabinoid (CBD)_medicines t
Enveric Biosciences Appoints Dr. Douglas D. Lind to Company's Board of Directors
08:00am, Thursday, 18'th Mar 2021
NEW YORK, March 18, 2021 /PRNewswire/ -- Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a patient-first biotechnology company developing novel cannabinoid medicines to improve qu
LOS ANGELES, CA / ACCESSWIRE / March 17, 2021 / SNN Network, The Official Small-, Micro- and Nano-Cap News Source™, today published a new Video Interview with David Johnson, Chairman, and CEO of Env
ENVB Stock Price Increases Over 10% Pre-Market: Why It Happened
09:12am, Tuesday, 16'th Mar 2021
The stock price of Enveric Biosciences (NASDAQ: ENVB) has increased by over 10% pre-market. This is why it happened.
Diverse Biotech announces Strategic Transaction with Enveric Biosciences
08:21am, Tuesday, 16'th Mar 2021
ORLANDO, Fla., March 16, 2021 /PRNewswire/ -- Diverse Biotech, Inc. www.diversebiotech.com announced today that it has finalized a strategic transaction with Enveric Biosciences to license exclusive
Enveric Biosciences to Participate in Upcoming Investor Conferences in March
08:00am, Monday, 15'th Mar 2021
NAPLES, Fla., March 15, 2021 /PRNewswire/ -- Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a patient-first biotechnology company developing novel cannabinoid medicines to improve qu
CBD-focused Enveric Biosciences stock soars on heavy volume after license deal with cancer treatment company
12:34pm, Wednesday, 10'th Mar 2021
Shares of Enveric Biosciences Inc. doubled in very heavy volume in midday trading Wednesday, after the Florida-based biotechnology company focused on cannabinoid-based treatments and cancer treatments
Enveric Biosciences Stock Skyrockets After Licensing Agreement With Diverse Biotech
09:24am, Wednesday, 10'th Mar 2021
Enveric Biosciences Inc (NASDAQ: ENVB) soars in the premarket in reaction to acquiring an exclusive, perpetual license for novel molecules from Diverse Biotech. It is a biopharmaceutical company f
ENVB Stock Price Increased Over 80% Pre-Market: Why It Happened
09:12am, Wednesday, 10'th Mar 2021
The stock price of Enveric Biosciences Inc (NASDAQ: ENVB) increased by over 80% pre-market. This is why it happened.
Enveric Biosciences Inc. Announces $12.8 Million Registered Direct Offering
09:27am, Tuesday, 09'th Feb 2021
NAPLES, Fla., Feb. 9, 2021 /PRNewswire/ -- Enveric Biosciences Inc. (NASDAQ: ENVB) ("Enveric" or the "Company"), a patient-first biotechnology company developing novel cannabinoid medicines to improve
NEW YORK, Jan. 21, 2021 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty
Enveric Biosciences Inc. Announces Closing of $10 Million Registered Direct Offering
04:01pm, Friday, 15'th Jan 2021
NAPLES, Fla., Jan. 15, 2021 /PRNewswire/ -- Enveric Biosciences, Inc. (NASDAQ: ENVB) ("Enveric" or the "Company"), a patient-first biotechnology company developing novel cannabinoid medicines to impro
